Should you try a GLP-1 weight loss drug or surgery? Dr. Tim Woods of CoxHealth shares advice for both options. To report a ...

Scientists at the National Institute of Environmental Health Sciences have found that dog and cat allergens are present in ...

McDonald’s Corporation (NYSE:MCD) is a frequent feature of Cramer’s morning show. The fast food giant’s shares have lost 1.7% ...

The J. M. Smucker Company (NYSE:SJM) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...

The so-called 'King Kong' of weight-loss drugs can cause side effects like nausea, but may also help users build healthy ...

At this year’s National Restaurant Association Show, some of the industry’s leading executives stopped by FSR and QSR ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Hims & Hers Health HIMS. After $NVO Novo Nordisk abruptly terminated their partnership, citing "deceptive marketing," Hims & Hers fired back with confidence… saying they'll cont ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded ...

Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.